Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1997 1
1998 2
1999 2
2000 2
2001 1
2002 6
2003 2
2005 3
2006 1
2007 3
2008 4
2009 5
2010 5
2011 2
2012 5
2013 3
2014 2
2015 1
2016 6
2017 2
2018 2
2019 1
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Defining the needs for next generation assays for tuberculosis.
Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, Gilpin C, Boehme CC, Schito M, Kimerling M, Pai M. Denkinger CM, et al. Among authors: kimerling m. J Infect Dis. 2015 Apr 1;211 Suppl 2(Suppl 2):S29-38. doi: 10.1093/infdis/jiu821. J Infect Dis. 2015. PMID: 25765104 Free PMC article. Review.
How can mathematical models advance tuberculosis control in high HIV prevalence settings?
Houben RM, Dowdy DW, Vassall A, Cohen T, Nicol MP, Granich RM, Shea JE, Eckhoff P, Dye C, Kimerling ME, White RG; TB MAC TB-HIV meeting participants. Houben RM, et al. Among authors: kimerling me. Int J Tuberc Lung Dis. 2014 May;18(5):509-14. doi: 10.5588/ijtld.13.0773. Int J Tuberc Lung Dis. 2014. PMID: 24903784 Free PMC article. Review.
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences.
Tiemersma E, van den Hof S, Dravniece G, Wares F, Molla Y, Permata Y, Lukitosari E, Quelapio M, Aung ST, Aung KM, Thuy HT, Hoa VD, Sulaimanova M, Sagyndikova S, Makhmudova M, Soliev A, Kimerling M. Tiemersma E, et al. Among authors: kimerling m. Eur Respir Rev. 2019 Oct 11;28(153):180115. doi: 10.1183/16000617.0115-2018. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31604816 Free PMC article. Review.
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.
Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M. Wells WA, et al. Among authors: kimerling me. Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531393 Free PMC article. Review.
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis.
Horsburgh CR Jr, Haxaire-Theeuwes M, Lienhardt C, Wingfield C, McNeeley D, Pyne-Mercier L, Keshavjee S, Varaine F; Research Excellence to Stop TB Resistance (RESIST-TB); Critical Path to TB Drug Regimens' Access and Appropriate Use Workgroup. Horsburgh CR Jr, et al. Int J Tuberc Lung Dis. 2013 Feb;17(2):146-52. doi: 10.5588/ijtld.12.0017. Epub 2012 Dec 4. Int J Tuberc Lung Dis. 2013. PMID: 23211610 Review.
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.
Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S. Nahid P, et al. Among authors: kimerling me. J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S159-68. doi: 10.1093/infdis/jis194. Epub 2012 Apr 3. J Infect Dis. 2012. PMID: 22476718 Free PMC article. Review.
64 results